Compare Danaher Corporation (DHR) vs Microchip Technology Inc. (MCHP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Microchip Technology Inc. — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while Microchip Technology Inc. trades at $75.55 (market cap $41.01B). The key difference: Danaher Corporation is far larger — about 3.7× Microchip Technology Inc.'s market cap, and Microchip Technology Inc. pays the higher dividend (2.41%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and Microchip Technology Inc. for 63 Days on average.
| DHR | MCHP | |
|---|---|---|
Market Cap | $152.87B | $41.01B |
Volume | 5,228,698 | 9,972,516 |
Sector | Health | Technology |
52-Week High | $242.05 | $102.97 |
52-Week Low | $161.91 | $49.02 |
Typical Hold Time | 69 Days | 63 Days |
Enterprise Value | $175.08B | $46.13B |
Dividend Yield | 0.74% | 2.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
MCHP trades at $75.52, down 3.2% over 24 hours, with technical indicators showing a bearish trend. The company reported a net loss of -$500K in 2025, though it has consistently beaten EPS estimates in recent quarters. Recent news highlights expansion in Ethernet and 48V power portfolios, including the acquisition of Hailo, targeting automotive and industrial demand. Analyst consensus is strongly bullish with a $110.50 price target, but high valuation ratios and significant debt pose risks.
The outlook is mixed: strong analyst support and strategic expansions in AI and data centers offer growth potential, but high P/E of 111.06 and net income margin pressure from 2025 raise concerns. Investors face upside from earnings beats and sector demand against valuation and cyclical semiconductor risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →
